Mangoceuticals, Inc.
MGRX· Nasdaq
MGRXMangoceuticals, Inc.
Quarterly figures for Mangoceuticals, Inc., with source filings when available.
18 quarters. Mar 31, 2022 to Jun 30, 2026. USD.
Mangoceuticals, Inc. has filed its 10-Q within 44 to 49 days of period end across its last 8 quarters. The 10-K runs 79 to 92 days.
Mangoceuticals, Inc. · CIK 1938046 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 13, 2026 | 44 d | 10-Q | $68.76K | −59.1% | -$0.09 | |
| Q1 2026 | Mar 31, 2026 | — | May 19, 2026 | 49 d | 10-Q | ||||
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | — | Apr 1, 2026 | 91 d | 10-K | $94.36K | −10.3% | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 14, 2025 | ||||||
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Mar 20, 2025 | 79 d | 10-K | $105.25K | −56.9% | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 14, 2024 | ||||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Apr 1, 2024 | 92 d | 10-K | $244.37K | — | — | |
| Q3 2023 | Sep 30, 2023 | Oct 19, 2023 · market hours | Oct 27, 2023 | ||||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | — | — | — | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | — | — | — | — | — | -$0.10 | |
| Q2 2022 | |||||||||
| $67.86K |
| −37.9% |
| -$0.22 |
| 45 d |
| 10-Q |
| $84.25K |
| −36.8% |
| -$0.69 |
| Q2 2025 | Jun 30, 2025 | — | Aug 14, 2025 | 45 d | 10-Q | $168.11K | +3.0% | -$0.57 |
|---|
| Q1 2025 | Mar 31, 2025 | — | May 15, 2025 | 45 d | 10-Q | $109.31K | −48.9% | -$1.12 |
|---|
| 45 d |
| 10-Q |
| $133.37K |
| −45.6% |
| -$1.14 |
| Q2 2024 | Jun 30, 2024 | — | Aug 14, 2024 | 45 d | 10-Q | $163.16K | +15.5% | -$1.37 |
|---|
| Q1 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | $214.10K | +112.6% | -$1.50 |
|---|
| 27 d |
| 10-Q |
| $245.16K |
| — |
| -$1.70 |
| Q2 2023 | Jun 30, 2023 | — | Jul 28, 2023 | 28 d | 10-Q | $141.24K | — | -$0.14 |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 10, 2023 | 40 d | 10-Q | $100.72K | — | -$0.23 |
|---|
| Jun 30, 2022 |
| — |
| — |
| — |
| — |
| — |
| — |
| -$0.04 |
| Q1 2022 | Mar 31, 2022 | — | — | — | — | — | — | — |
|---|
